文献速递糖尿病

COVID-19与1型糖尿病:应对关切并维持控制

COVID-19 and Type 1 Diabetes: Addressing Concerns and Maintaining Control.
PubMed 文献 · Diabetes Care · 2021-06-26

本文讨论SARS-CoV-2大流行对1型糖尿病患者的影响。早期快速报告提供预警并指导医疗应对,但部分缺乏科学严谨性;许多报告未区分1型与2型糖尿病。现有证据表明,1型糖尿病患者因医疗可及性受限及感染后发病率/死亡率增加而受到急性影响。

要点

  • 1型糖尿病患者在疫情期间因医疗可及性受限而受到急性影响,尤其在封锁期间。
  • 感染COVID-19的1型糖尿病成人患者较无糖尿病的同龄人发病率和死亡率增加。
  • 许多COVID-19与「糖尿病」的报告未区分1型与2型糖尿病,解读时需谨慎。

核心结论

  • 现有证据表明1型糖尿病患者因COVID-19在医疗可及性和感染后结局方面受到急性影响。

主要发现

  • 感染COVID-19的1型糖尿病成人患者较无糖尿病的同龄人发病率和死亡率增加。
  • 封锁期间1型糖尿病患者获得医疗服务受限。

局限性

  • 许多COVID-19与「糖尿病」的报告未区分1型与2型糖尿病。
  • 部分早期快速报告缺乏科学严谨性或可重复性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an unprecedented pandemic. Early on, even as the signs and symptoms of coronavirus disease 2019 (COVID-19) were first characterized, significant concerns were articulated regarding its potential impact on people with chronic disease, including type 1 diabetes. Information about the basic and clinical interrelationships between COVID-19 and diabetes has rapidly emerged. Initial rapid reports were useful to provide alerts and guide health care responses and initial policies. Some of these have proven subsequently to have durable findings, whereas others lacked scientific rigor/reproducibility. Many publications that report on COVID-19 and "diabetes" also have not distinguished between type 1 and type 2 (1). Available evidence now demonstrates that people with type 1 diabetes have been acutely affected by COVID-19 in multiple ways. This includes effects from limited access to health care, particularly during lockdown periods, and increased morbidity/mortality in infected adults with type 1 diabetes compared with peers without diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. DiMeglio LA. COVID-19 and Type 1 Diabetes: Addressing Concerns and Maintaining Control. Diabetes Care. 2021. PMID: 34175828. doi:10.2337/dci21-0002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。